PureTech Health Financials

PRTC Stock

128.80 0.80 0.63%

We recommend to use PureTech Health plc fundamental analysis to see if markets are presently undervaluing or overvaluing the firm. Put it differently, this technique allows you to confirm available drivers of PureTech Health plc as well as the relationship between them. We are able to interpolate and collect twenty-seven available financial ratios for PureTech Health plc, which can be compared to its competitors. The stock experiences a moderate upward volatility. Check odds of PureTech Health to be traded at 141.68 in 90 days.

Yuan Drop

Covid

Interest Hikes

PureTech Health Balance Sheet Chart

At this time, PureTech Health's Short Term Investments are comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 185.1 M in 2026, whereas Other Current Liabilities is likely to drop slightly above 30.7 M in 2026.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Key indicators impacting PureTech Health's financial strength include:

Operating Margin

(25.90)

PE Ratio

10.6667

Profit Margin

7.9296

EPS Estimate Current Year

(0.60)

Return On Equity

0.0944

Please note, the imprecision that can be found in PureTech Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of PureTech Health plc. Check PureTech Health's Beneish M Score to see the likelihood of PureTech Health's management manipulating its earnings.

PureTech Health Stock Summary

PureTech Health competes with Samsung Electronics, Samsung Electronics, Samsung Electronics, Toyota, and Samsung SDI. PureTech Health is entity of United Kingdom. It is traded as Stock on LSE exchange.

Foreign Associate	USA
Specialization	Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Instrument	UK Stock View All
Exchange	London Exchange
ISIN	GB00BY2Z0H74
Business Address	6 Tide Street,
Sector	Life Sciences Tools & Services
Industry	Health Care
Benchmark	Dow Jones Industrial
Website	www.puretechhealth.com
Phone	617 482 2333

You should never invest in PureTech Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of PureTech Stock, because this is throwing your money away. Analyzing the key information contained in PureTech Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

PureTech Health Key Financial Ratios

There are many critical financial ratios that PureTech Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that PureTech Health plc reports annually and quarterly.

	Revenue	4.32 M
	Gross Profit	(48.81 M)
	EBITDA	37.38 M
	Net Income	27.78 M
	Total Asset	602.63 M

More Fundamentals

PureTech Health Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	946.0M	702.6M	694.0M	602.6M	693.0M	554.0M
Other Current Liab	174.0M	57.9M	29.6M	28.1M	32.3M	30.7M
Other Liab	116.7M	108.6M	92.4M	23.8M	27.3M	36.5M
Net Debt	(413.7M)	(103.0M)	(165.7M)	(121.5M)	(109.3M)	(114.8M)
Retained Earnings	199.9M	149.5M	83.8M	32.5M	37.4M	23.4M
Accounts Payable	11.3M	26.5M	14.6M	5.5M	6.4M	8.0M
Cash	465.7M	149.9M	191.1M	280.6M	322.7M	190.2M
Net Receivables	3.6M	12.3M	2.4M	12.9M	14.8M	15.6M
Other Current Assets	32.5M	23.8M	17.7M	6.0M	7.0M	10.4M
Total Liab	361.9M	155.1M	235.7M	194.7M	223.9M	223.0M
Total Current Assets	501.8M	386.2M	347.2M	386.3M	444.2M	297.7M
Short Term Debt	9.4M	12.5M	7.1M	7.7M	8.8M	9.3M
Intangible Assets	987K	831K	906K	601K	540.9K	513.9K
Common Stock	5.4M	5.5M	5.5M	4.9M	4.4M	4.2M
Net Tangible Assets	667.4M	668.8M	592.5M	541.4M	622.6M	369.1M
Short Long Term Debt	4.8M	7.5M	3.7M	4.1M	4.7M	8.3M
Net Invested Capital	612.5M	560.0M	467.8M	418.8M	481.6M	543.0M
Net Working Capital	275.7M	289.3M	295.8M	344.9M	396.6M	416.4M

PureTech Health Key Income Statement Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Interest Expense	4.7M	4.0M	13.5M	10.0M	11.5M	12.1M
Total Revenue	10.0M	2.1M	750K	4.3M	3.9M	5.2M
Gross Profit	(100.5M)	(136.8M)	(92.9M)	4.3M	3.9M	4.1M
Operating Income	(150.3M)	(197.8M)	(146.2M)	(136.1M)	(122.5M)	(128.6M)
Ebit	(54.2M)	(88.8M)	(22.6M)	33.8M	38.9M	40.8M
Research Development	81.5M	116.1M	96.2M	54.3M	62.4M	56.5M
Ebitda	(47.0M)	(79.9M)	(17.7M)	37.4M	43.0M	45.1M
Income Before Tax	(59.0M)	(92.8M)	(36.1M)	23.8M	27.3M	28.7M
Net Income	(60.6M)	(50.4M)	(65.7M)	53.5M	61.5M	64.6M
Income Tax Expense	3.8M	(55.7M)	30.5M	(4.0M)	(4.6M)	(4.4M)
Minority Interest	2.2M	(13.3M)	931K	25.7M	29.6M	31.1M
Tax Provision	3.8M	(55.7M)	30.5M	(4.0M)	(3.6M)	(3.4M)
Net Interest Income	(4.5M)	1.8M	2.5M	12.6M	14.5M	15.3M
Interest Income	214K	5.8M	16.0M	22.7M	26.1M	27.4M

PureTech Health Key Cash Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Change In Cash	61.8M	(315.8M)	41.2M	89.6M	80.6M	84.6M
Free Cash Flow	(163.9M)	(181.0M)	(106.2M)	(134.4M)	(120.9M)	(127.0M)
Depreciation	7.3M	8.9M	4.9M	3.6M	4.1M	3.9M
Other Non Cash Items	(5.1M)	(181.2M)	(62.6M)	(178.3M)	(160.5M)	(152.5M)
Capital Expenditures	5.7M	2.2M	245K	11K	12.7K	12.0K
Net Income	(62.7M)	(37.1M)	(66.6M)	27.8M	31.9M	33.5M
End Period Cash Flow	465.7M	149.9M	191.1M	280.6M	322.7M	176.9M
Investments	197.4M	(107.2M)	69.0M	240.9M	277.0M	290.9M

PureTech Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PureTech Health's current stock value. Our valuation model uses many indicators to compare PureTech Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PureTech Health competition to find correlations between indicators driving PureTech Health's intrinsic value. More Info.

PureTech Health plc is regarded second in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PureTech Health's earnings, one of the primary drivers of an investment's value.

PureTech Health plc Total Assets Over Time

Most indicators from PureTech Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PureTech Health plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Selling General Administrative is likely to drop to about 27.2 M in 2026. Discontinued Operations is likely to drop to about 340 K in 2026

	2023	2024	2025	2026 (projected)
Interest Expense	13.5M	10.0M	11.5M	12.1M
Depreciation And Amortization	4.9M	3.6M	4.1M	3.7M

Interest Expense Depreciation And Amortization

PureTech Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.5	0.34	0.36	0.99	0.84	0.93	0.02	-0.72	0.77	0.69	0.81	0.91	0.75	0.52	0.81	0.4	-0.14	0.82	0.36	0.81	0.59	0.63	0.93	0.87	0.91
Short Long Term Debt Total	0.5		-0.17	-0.24	0.5	0.3	0.35	-0.1	-0.22	0.33	0.24	0.57	0.34	0.3	-0.07	0.55	0.91	-0.14	0.64	0.09	0.77	0.7	0.17	0.5	0.35	0.46
Other Current Liab	0.34	-0.17		0.94	0.29	0.25	0.26	0.03	-0.31	-0.1	0.08	0.19	0.29	0.38	0.45	0.3	-0.23	-0.17	0.2	0.43	-0.08	0.0	0.31	0.5	0.7	0.16
Total Current Liabilities	0.36	-0.24	0.94		0.32	0.28	0.28	0.32	-0.42	-0.1	0.07	0.25	0.26	0.38	0.44	0.4	-0.32	-0.03	0.09	0.52	-0.13	-0.06	0.32	0.51	0.71	0.16
Total Stockholder Equity	0.99	0.5	0.29	0.32		0.83	0.93	0.02	-0.69	0.78	0.73	0.78	0.91	0.72	0.49	0.79	0.44	-0.11	0.82	0.34	0.8	0.55	0.61	0.92	0.83	0.92
Other Liab	0.84	0.3	0.25	0.28	0.83		0.91	-0.18	-0.65	0.87	0.44	0.65	0.94	0.67	0.69	0.45	0.12	-0.16	0.67	-0.02	0.67	0.42	0.39	0.64	0.7	0.77
Property Plant And Equipment Net	0.93	0.35	0.26	0.28	0.93	0.91		-0.13	-0.66	0.89	0.76	0.69	0.93	0.78	0.59	0.62	0.32	-0.2	0.77	0.25	0.7	0.48	0.66	0.77	0.73	0.95
Current Deferred Revenue	0.02	-0.1	0.03	0.32	0.02	-0.18	-0.13		-0.2	-0.34	-0.1	0.11	-0.23	-0.18	-0.11	0.38	-0.12	0.4	-0.37	0.52	-0.17	-0.1	0.03	0.14	0.14	-0.13
Net Debt	-0.72	-0.22	-0.31	-0.42	-0.69	-0.65	-0.66	-0.2		-0.55	-0.36	-0.91	-0.54	-0.79	-0.4	-0.75	-0.08	-0.24	-0.45	-0.26	-0.5	-0.61	-0.66	-0.6	-0.69	-0.64
Retained Earnings	0.77	0.33	-0.1	-0.1	0.78	0.87	0.89	-0.34	-0.55		0.65	0.6	0.86	0.66	0.46	0.37	0.29	-0.15	0.68	-0.11	0.71	0.45	0.47	0.49	0.43	0.85
Accounts Payable	0.69	0.24	0.08	0.07	0.73	0.44	0.76	-0.1	-0.36	0.65		0.39	0.63	0.58	0.23	0.53	0.45	-0.16	0.64	0.45	0.51	0.31	0.75	0.63	0.42	0.85
Cash	0.81	0.57	0.19	0.25	0.78	0.65	0.69	0.11	-0.91	0.6	0.39		0.59	0.76	0.3	0.86	0.41	0.13	0.65	0.25	0.71	0.76	0.59	0.71	0.71	0.72
Non Current Assets Total	0.91	0.34	0.29	0.26	0.91	0.94	0.93	-0.23	-0.54	0.86	0.63	0.59		0.63	0.65	0.49	0.24	-0.2	0.79	0.07	0.75	0.41	0.44	0.76	0.75	0.84
Non Currrent Assets Other	0.75	0.3	0.38	0.38	0.72	0.67	0.78	-0.18	-0.79	0.66	0.58	0.76	0.63		0.22	0.66	0.25	-0.17	0.64	0.22	0.52	0.5	0.67	0.64	0.68	0.75
Other Assets	0.52	-0.07	0.45	0.44	0.49	0.69	0.59	-0.11	-0.4	0.46	0.23	0.3	0.65	0.22		0.16	-0.17	-0.1	0.37	0.16	0.25	0.25	0.38	0.43	0.54	0.48
Cash And Short Term Investments	0.81	0.55	0.3	0.4	0.79	0.45	0.62	0.38	-0.75	0.37	0.53	0.86	0.49	0.66	0.16		0.49	0.01	0.59	0.64	0.63	0.66	0.66	0.86	0.77	0.7
Net Receivables	0.4	0.91	-0.23	-0.32	0.44	0.12	0.32	-0.12	-0.08	0.29	0.45	0.41	0.24	0.25	-0.17	0.49		-0.11	0.6	0.21	0.62	0.56	0.29	0.44	0.19	0.49
Common Stock Total Equity	-0.14	-0.14	-0.17	-0.03	-0.11	-0.16	-0.2	0.4	-0.24	-0.15	-0.16	0.13	-0.2	-0.17	-0.1	0.01	-0.11		-0.19	-0.25	-0.2	-0.17	-0.12	-0.2	-0.17	-0.21
Common Stock Shares Outstanding	0.82	0.64	0.2	0.09	0.82	0.67	0.77	-0.37	-0.45	0.68	0.64	0.65	0.79	0.64	0.37	0.59	0.6	-0.19		0.14	0.82	0.61	0.52	0.76	0.65	0.81
Short Term Investments	0.36	0.09	0.43	0.52	0.34	-0.02	0.25	0.52	-0.26	-0.11	0.45	0.25	0.07	0.22	0.16	0.64	0.21	-0.25	0.14		0.11	0.31	0.66	0.56	0.49	0.37
Non Current Liabilities Total	0.81	0.77	-0.08	-0.13	0.8	0.67	0.7	-0.17	-0.5	0.71	0.51	0.71	0.75	0.52	0.25	0.63	0.62	-0.2	0.82	0.11		0.79	0.43	0.7	0.61	0.75
Inventory	0.59	0.7	0.0	-0.06	0.55	0.42	0.48	-0.1	-0.61	0.45	0.31	0.76	0.41	0.5	0.25	0.66	0.56	-0.17	0.61	0.31	0.79		0.63	0.53	0.52	0.6
Other Current Assets	0.63	0.17	0.31	0.32	0.61	0.39	0.66	0.03	-0.66	0.47	0.75	0.59	0.44	0.67	0.38	0.66	0.29	-0.12	0.52	0.66	0.43	0.63		0.59	0.56	0.77
Other Stockholder Equity	0.93	0.5	0.5	0.51	0.92	0.64	0.77	0.14	-0.6	0.49	0.63	0.71	0.76	0.64	0.43	0.86	0.44	-0.2	0.76	0.56	0.7	0.53	0.59		0.91	0.79
Total Liab	0.87	0.35	0.7	0.71	0.83	0.7	0.73	0.14	-0.69	0.43	0.42	0.71	0.75	0.68	0.54	0.77	0.19	-0.17	0.65	0.49	0.61	0.52	0.56	0.91		0.67
Property Plant And Equipment Gross	0.91	0.46	0.16	0.16	0.92	0.77	0.95	-0.13	-0.64	0.85	0.85	0.72	0.84	0.75	0.48	0.7	0.49	-0.21	0.81	0.37	0.75	0.6	0.77	0.79	0.67

Click cells to compare fundamentals

PureTech Health Account Relationship Matchups

PureTech Health fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	946.0M	702.6M	694.0M	602.6M	693.0M	554.0M
Other Current Liab	174.0M	57.9M	29.6M	28.1M	32.3M	30.7M
Other Liab	116.7M	108.6M	92.4M	23.8M	27.3M	36.5M
Net Debt	(413.7M)	(103.0M)	(165.7M)	(121.5M)	(109.3M)	(114.8M)
Retained Earnings	199.9M	149.5M	83.8M	32.5M	37.4M	23.4M
Accounts Payable	11.3M	26.5M	14.6M	5.5M	6.4M	8.0M
Cash	465.7M	149.9M	191.1M	280.6M	322.7M	190.2M
Net Receivables	3.6M	12.3M	2.4M	12.9M	14.8M	15.6M
Other Current Assets	32.5M	23.8M	17.7M	6.0M	7.0M	10.4M
Total Liab	361.9M	155.1M	235.7M	194.7M	223.9M	223.0M
Total Current Assets	501.8M	386.2M	347.2M	386.3M	444.2M	297.7M
Short Term Debt	9.4M	12.5M	7.1M	7.7M	8.8M	9.3M
Intangible Assets	987K	831K	906K	601K	540.9K	513.9K
Common Stock	5.4M	5.5M	5.5M	4.9M	4.4M	4.2M
Net Tangible Assets	667.4M	668.8M	592.5M	541.4M	622.6M	369.1M
Short Long Term Debt	4.8M	7.5M	3.7M	4.1M	4.7M	8.3M
Net Invested Capital	612.5M	560.0M	467.8M	418.8M	481.6M	543.0M
Net Working Capital	275.7M	289.3M	295.8M	344.9M	396.6M	416.4M

PureTech Health Thematic Clasifications

PureTech Health plc is part of several thematic ideas from Health Management to IT. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas

	Health Management		View
	IT		View

PureTech Health February 14, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of PureTech Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PureTech Health plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of PureTech Health plc based on widely used predictive technical indicators. In general, we focus on analyzing PureTech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PureTech Health's daily price indicators and compare them against related drivers.

	Downside Deviation	1.43
	Information Ratio	(0.01)
	Maximum Drawdown	7.35
	Value At Risk	(2.46)
	Potential Upside	2.54

Additional Tools for PureTech Stock Analysis

When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC